Clinical characteristics of mammary carcinoma in male cats

Katherine A Skorupski, Beth Overley, Frances S. Shofer, Michael H. Goldschmidt, Carrie A. Miller, Karin U. Sørenmo

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

There is little information regarding mammary tumors in male cats. The purpose of this study was to characterize the clinical characteristics of mammary carcinoma in male cats, compare this malignancy to the disease in female cats, and identify prognostic factors. Thirty-nine male cats with mammary carcinoma were identified. One pathologist reviewed the biopsies from all cats, and complete follow-up information regarding outcome was available for 27 cats. Information collected included signalment, age at neutering, history of progestin therapy, age at tumor diagnosis, size of tumor, type of surgery (lumpectomy, simple mastectomy, or radical mastectomy), results of clinical staging, adjunctive therapies, time to local recurrence, survival, and cause of death. The mean age at tumor diagnosis (12.8 years) was slightly older than that reported in female cats. The incidence of local tumor recurrence in 9 of 20 (45%) cats was similar to that reported in females. A history of progestin therapy was present in 8 of 22 (36%) cats for which this information was known. The median time to local recurrence was 310 days (range 127-1,363 days), and overall median survival was 344 days (range 14-2,135 days). Tumor size and lymphatic invasion were identified as negative prognostic factors. This study indicates that mammary carcinoma in the male cat has many similarities to the disease in females, with an aggressive clinical course in most cats.

Original languageEnglish (US)
Pages (from-to)52-55
Number of pages4
JournalJournal of Veterinary Internal Medicine
Volume19
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

breast neoplasms
Cats
cats
Breast Neoplasms
neoplasms
Neoplasms
progestational hormones
Progestins
Recurrence
therapeutics
Simple Mastectomy
Radical Mastectomy
Segmental Mastectomy
mammary neoplasms (animal)
castration
disease course
biopsy
Cause of Death
Therapeutics
surgery

Keywords

  • Male cat
  • Mammary gland tumor
  • Progestin
  • Prognostic factor

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Clinical characteristics of mammary carcinoma in male cats. / Skorupski, Katherine A; Overley, Beth; Shofer, Frances S.; Goldschmidt, Michael H.; Miller, Carrie A.; Sørenmo, Karin U.

In: Journal of Veterinary Internal Medicine, Vol. 19, No. 1, 01.2005, p. 52-55.

Research output: Contribution to journalArticle

Skorupski, Katherine A ; Overley, Beth ; Shofer, Frances S. ; Goldschmidt, Michael H. ; Miller, Carrie A. ; Sørenmo, Karin U. / Clinical characteristics of mammary carcinoma in male cats. In: Journal of Veterinary Internal Medicine. 2005 ; Vol. 19, No. 1. pp. 52-55.
@article{934e7a487f37400f93583cee6d7d4e1c,
title = "Clinical characteristics of mammary carcinoma in male cats",
abstract = "There is little information regarding mammary tumors in male cats. The purpose of this study was to characterize the clinical characteristics of mammary carcinoma in male cats, compare this malignancy to the disease in female cats, and identify prognostic factors. Thirty-nine male cats with mammary carcinoma were identified. One pathologist reviewed the biopsies from all cats, and complete follow-up information regarding outcome was available for 27 cats. Information collected included signalment, age at neutering, history of progestin therapy, age at tumor diagnosis, size of tumor, type of surgery (lumpectomy, simple mastectomy, or radical mastectomy), results of clinical staging, adjunctive therapies, time to local recurrence, survival, and cause of death. The mean age at tumor diagnosis (12.8 years) was slightly older than that reported in female cats. The incidence of local tumor recurrence in 9 of 20 (45{\%}) cats was similar to that reported in females. A history of progestin therapy was present in 8 of 22 (36{\%}) cats for which this information was known. The median time to local recurrence was 310 days (range 127-1,363 days), and overall median survival was 344 days (range 14-2,135 days). Tumor size and lymphatic invasion were identified as negative prognostic factors. This study indicates that mammary carcinoma in the male cat has many similarities to the disease in females, with an aggressive clinical course in most cats.",
keywords = "Male cat, Mammary gland tumor, Progestin, Prognostic factor",
author = "Skorupski, {Katherine A} and Beth Overley and Shofer, {Frances S.} and Goldschmidt, {Michael H.} and Miller, {Carrie A.} and S{\o}renmo, {Karin U.}",
year = "2005",
month = "1",
doi = "10.1892/0891-6640(2005)19<52:CCOMCI>2.0.CO;2",
language = "English (US)",
volume = "19",
pages = "52--55",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Clinical characteristics of mammary carcinoma in male cats

AU - Skorupski, Katherine A

AU - Overley, Beth

AU - Shofer, Frances S.

AU - Goldschmidt, Michael H.

AU - Miller, Carrie A.

AU - Sørenmo, Karin U.

PY - 2005/1

Y1 - 2005/1

N2 - There is little information regarding mammary tumors in male cats. The purpose of this study was to characterize the clinical characteristics of mammary carcinoma in male cats, compare this malignancy to the disease in female cats, and identify prognostic factors. Thirty-nine male cats with mammary carcinoma were identified. One pathologist reviewed the biopsies from all cats, and complete follow-up information regarding outcome was available for 27 cats. Information collected included signalment, age at neutering, history of progestin therapy, age at tumor diagnosis, size of tumor, type of surgery (lumpectomy, simple mastectomy, or radical mastectomy), results of clinical staging, adjunctive therapies, time to local recurrence, survival, and cause of death. The mean age at tumor diagnosis (12.8 years) was slightly older than that reported in female cats. The incidence of local tumor recurrence in 9 of 20 (45%) cats was similar to that reported in females. A history of progestin therapy was present in 8 of 22 (36%) cats for which this information was known. The median time to local recurrence was 310 days (range 127-1,363 days), and overall median survival was 344 days (range 14-2,135 days). Tumor size and lymphatic invasion were identified as negative prognostic factors. This study indicates that mammary carcinoma in the male cat has many similarities to the disease in females, with an aggressive clinical course in most cats.

AB - There is little information regarding mammary tumors in male cats. The purpose of this study was to characterize the clinical characteristics of mammary carcinoma in male cats, compare this malignancy to the disease in female cats, and identify prognostic factors. Thirty-nine male cats with mammary carcinoma were identified. One pathologist reviewed the biopsies from all cats, and complete follow-up information regarding outcome was available for 27 cats. Information collected included signalment, age at neutering, history of progestin therapy, age at tumor diagnosis, size of tumor, type of surgery (lumpectomy, simple mastectomy, or radical mastectomy), results of clinical staging, adjunctive therapies, time to local recurrence, survival, and cause of death. The mean age at tumor diagnosis (12.8 years) was slightly older than that reported in female cats. The incidence of local tumor recurrence in 9 of 20 (45%) cats was similar to that reported in females. A history of progestin therapy was present in 8 of 22 (36%) cats for which this information was known. The median time to local recurrence was 310 days (range 127-1,363 days), and overall median survival was 344 days (range 14-2,135 days). Tumor size and lymphatic invasion were identified as negative prognostic factors. This study indicates that mammary carcinoma in the male cat has many similarities to the disease in females, with an aggressive clinical course in most cats.

KW - Male cat

KW - Mammary gland tumor

KW - Progestin

KW - Prognostic factor

UR - http://www.scopus.com/inward/record.url?scp=13544264650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13544264650&partnerID=8YFLogxK

U2 - 10.1892/0891-6640(2005)19<52:CCOMCI>2.0.CO;2

DO - 10.1892/0891-6640(2005)19<52:CCOMCI>2.0.CO;2

M3 - Article

C2 - 15715048

AN - SCOPUS:13544264650

VL - 19

SP - 52

EP - 55

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

SN - 0891-6640

IS - 1

ER -